Citation Impact
Citing Papers
The gut microbiota and host health: a new clinical frontier
2015 Standout
Enterocolitis due to immune checkpoint inhibitors: a systematic review
2018
Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis
2018 StandoutNobel
Food-grade TiO2 impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colon
2017 Standout
Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis
2012
The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis
2014
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Control of Regulatory T Cells by Co-signal Molecules
2019 StandoutNobel
Chemokine isoforms and processing in inflammation and immunity
2017
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
General health maintenance in IBD
2009
Guidelines of care for the management of psoriasis and psoriatic arthritis
2008
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA
2010
Rheumatoid arthritis
2018 Standout
Health Maintenance in the Inflammatory Bowel Disease Patient
2012
Hidradenitis suppurativa: A comprehensive review
2009 Standout
The First Endoscopy in Suspected Inflammatory Bowel Disease
2016
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis
2010
CD28 Costimulation: From Mechanism to Therapy
2016
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Subunit disassembly and inhibition of TNFα by a semi-synthetic bicyclic peptide
2015 StandoutNobel
Macrophages in immunoregulation and therapeutics
2023 Standout
Crohn's disease
2012 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
2009
Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review
2011
Biomarkers in Search of Precision Medicine in IBD
2016
New therapies for inflammatory bowel disease: from the bench to the bedside
2011
European evidenced-based consensus on reproduction in inflammatory bowel disease
2010
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
EULAR recommendations for vaccination in paediatric patients with rheumatic diseases
2011
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
2007
Systematic Review and Meta-Analysis of the Efficacy and Safety of Existing TNF Blocking Agents in Treatment of Rheumatoid Arthritis
2012
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Graphical Tools for Network Meta-Analysis in STATA
2013 Standout
Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis
2013 StandoutNobel
Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics
2009
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
Chronic inflammatory diseases: Do immunological patterns drive the choice of biotechnology drugs? A critical review
2014
Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis
2021
The Effect of Infliximab and Timing of Vaccination on the Humoral Response to Influenza Vaccination in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
2009
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
2017
The emerging safety profile of JAK inhibitors in rheumatic disease
2017
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
2012
Ulcerative colitis
2016 Standout
Rheumatoid arthritis
2010 Standout
BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies
2010
Safety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab
2012
Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies
2015
Hidradenitis suppurativa
2020 Standout
IL-28B is a Key Regulator of B- and T-Cell Vaccine Responses against Influenza
2014 StandoutNobel
Guidelines of care for the management of psoriasis and psoriatic arthritis
2008
A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview
2009
Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial
2009
Ulcerative colitis
2020 Standout
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: A prospective, open-label, parallel-cohort, single-center study
2011
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
2019 Standout
The Second European Evidenced-Based Consensus on Reproduction and Pregnancy in Inflammatory Bowel Disease
2014
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
2014 Standout
New targets for mucosal healing and therapy in inflammatory bowel diseases
2013
The global burden of IBD: from 2015 to 2025
2015 Standout
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Review article: chronic viral infection in the anti‐tumour necrosis factor therapy era in inflammatory bowel disease
2009
CXCR3 ligands in disease and therapy
2014
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
The biosimilar road in inflammatory bowel disease: The right way?
2014
IOIBD technical review on endoscopic indices for Crohn's disease clinical trials
2015
Computational design of a synthetic PD-1 agonist
2021 StandoutNobel
Treatment with the Interleukin-17A-Blocking Antibody Secukinumab Does Not Interfere with the Efficacy of Influenza and Meningococcal Vaccinations in Healthy Subjects: Results of an Open-Label, Parallel-Group, Randomized Single-Center Study
2012
Regulatory T Cells and Human Disease
2020 StandoutNobel
Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis
2018
The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases
2013
Psoriasis Pathogenesis and Treatment
2019 Standout
CTLA-4: a moving target in immunotherapy
2017
Early-onset Crohn’s disease and autoimmunity associated with a variant in CTLA-4
2014
Atherosclerotic Plaque Healing
2020
Translating Immunology into Therapeutic Concepts for Inflammatory Bowel Disease
2018
Prosthetic Joint Infection
2014 Standout
Protective effects of Fc-fused PD-L1 on two different animal models of colitis
2014
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics
2017
Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines
2013
Systematic review: colitis associated with anti‐CTLA ‐4 therapy
2015
Costimulation Blockade in Autoimmunity and Transplantation: The CD28 Pathway
2016
JAK inhibitors for alopecia areata: a systematic review and meta‐analysis
2019
Works of Allison Luo being referenced
Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study
2013
Abatacept for Crohn's Disease and Ulcerative Colitis
2012
Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of up to 8 Years of Treatment from the Abatacept Clinical Trial Program
2013
Abatacept in subjects who switch from intravenous to subcutaneous therapy: results from the phase IIIb ATTUNE study
2012
Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study
2015
A phase II, randomized, double‐blind, placebo‐controlled study evaluating the efficacy and safety of MDX‐1100, a fully human anti‐CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis
2011
649 A Randomized Placebo-Controlled Trial of Abatacept for Moderately-to-Severely Active Crohn's Disease (CD)
2010
Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab.
2007
Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn's disease
2015
A randomized, double‐blind, placebo‐controlled, phase III study of the human anti‐tumor necrosis factor antibody adalimumab administered as subcutaneous injections in Korean rheumatoid arthritis patients treated with methotrexate
2007